• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Bye-Bye China?

    Decentralized Trials Fuel AI Revolution in Clinical Research

    Self-Medication: Flexibility for Patients and Drug Manufacturers

    The Single-Use Mixing Landscape: Evaluating Your Options

    DCAT President Talks COVID-19, Drug Manufacturing and Innovation
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Stevanato Group Launches After-sales Service Offering

    X-Chem Acquires IntelliSyn and AviSyn

    Aphena’s $21M Cookeville Expansion Nears Completion

    BioMed X, Janssen Enter Oral Drug Delivery Alliance

    Care Access Research, AstraZeneca Partner on COVID-19 Antibody Trial
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Aphena’s $21M Cookeville Expansion Nears Completion

    PromoCell Receives EXCiPACT Certification

    Civica to Build an Essential Medicines Manufacturing Facility in Virginia

    Humanigen, Emergent Enter Covid-19 Partnership

    Samsung Bioepis Opens New Headquarters
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Aphena’s $21M Cookeville Expansion Nears Completion

    Civica to Build an Essential Medicines Manufacturing Facility in Virginia

    WDSrx Expands Warehouse Network

    Catalent Acquires Acorda’s INBRIJA Manufacturing Operations

    Varcode, PL Developments Form Strategic ‘Smart Tag’ Pact
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    The Future of Clinical Trials Series: Part II

    X-Chem Acquires IntelliSyn and AviSyn

    Care Access Research, AstraZeneca Partner on COVID-19 Antibody Trial

    Caprion-HistoGeneX Rebrands as CellCarta

    Humanigen, Emergent Enter Covid-19 Partnership
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Top BioPharma Form Accumulus Synergy

    Global Biosciences Co. Selects ValGenesis VLMS

    Gene Therapy Co. Selects ValGenesis' SaaS Platform

    The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021

    Samsung Biologics Adopts Veeva Vault QMS to Unify Quality Management
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Cytovance Biologics

    Reed-Lane

    Aphena Pharma Solutions

    Almac Group

    Alcami
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    PCI Pharma Services

    Cytovance Biologics

    Almac Group

    Alcami

    Adare Pharma Solutions
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    Crown Biosciences Opens Facility in China

    Full operational capacity is expected in early 2021.

    Crown Biosciences Opens Facility in China
    Once completed, the new building will add more vivarium space to support CrownBio’s in vivo oncology platforms.
    Related CONTENT
    • The Future of Clinical Trials Series: Part II
    • WDSrx Expands Warehouse Network
    • NovaQuest Private Equity Acquires CoreRx
    • Valeo Pharma Appoints President, COO
    • Cognate BioServices Announces Major Expansion
    Contract Pharma Staff11.03.20
    Crown Bioscience, a JSR Life Sciences company, has opened a new oncology-focused research facility in Zhongshan, China to satisfy increased customer demand.
     
    Once completed, this new building will add more than 2,000m2 of new vivarium space to support CrownBio’s in vivo oncology platforms, helping satisfy predicted near-term growth.
     
    CrownBio’s products and services are used by pharmaceutical and biotech customers across APAC, North America, and Europe to accelerate and de-risk their drug discovery programs. With the significant and continued growth of CrownBio’s client base, the Zhongshan facility has been purpose-built to meet expanding study needs.
     
    The research and drug development facility features BSL-2 laboratories and will include an ABSL-2 vivarium. Initial capabilities will focus on expanding cell line-derived xenograft model availability and study throughput, with an increased roster of cutting edge, translational oncology models becoming available. Full operational capacity is expected in early 2021.
     
    “The establishment of our new Zhongshan facility demonstrates our continued commitment to our clients, to provide sustained rapid study initiation combined with robust cost-effectiveness,” said John Gu, chief operating officer at CrownBio. “Through our growth, we can more fully support our clients in their goals of more rapid and efficient cancer drug development.”
     
    A site opening event and ribbon cutting ceremony took place on October 30, 2020.
    Suggested For You
    The Future of Clinical Trials Series: Part II The Future of Clinical Trials Series: Part II
    WDSrx Expands Warehouse Network WDSrx Expands Warehouse Network
    NovaQuest Private Equity Acquires CoreRx NovaQuest Private Equity Acquires CoreRx
    Valeo Pharma Appoints President, COO Valeo Pharma Appoints President, COO
    Cognate BioServices Announces Major Expansion Cognate BioServices Announces Major Expansion
    Cytiva Delivers Modular Biologics Factory to Lonza Cytiva Delivers Modular Biologics Factory to Lonza
    Fujifilm Diosynth Biotechnologies Begins COVID-19 Vax Production Fujifilm Diosynth Biotechnologies Begins COVID-19 Vax Production
    AmbioPharm Opens New Shanghai Campus AmbioPharm Opens New Shanghai Campus
    Alcami Expands Oral Solid Capabilities with Investment in Wilmington, NC Alcami Expands Oral Solid Capabilities with Investment in Wilmington, NC
    Aurigene Pharmaceutical Services ltd. Aurigene Pharmaceutical Services ltd.
    INOVIO, Advaccine Enter Exclusive COVID-19 DNA Vax Pact  INOVIO, Advaccine Enter Exclusive COVID-19 DNA Vax Pact
    Lonza Expands Conjugation Facility in Visp Lonza Expands Conjugation Facility in Visp
    BioNTech, Shanghai Fosun Pharma to Supply COVID-19 Vax to China BioNTech, Shanghai Fosun Pharma to Supply COVID-19 Vax to China
    Abenza Promotes Kimball Hall to President Abenza Promotes Kimball Hall to President
    Passage Bio Invests in Gene Therapy Manufacturing R&D Site Passage Bio Invests in Gene Therapy Manufacturing R&D Site

    Related Breaking News

    • Breaking News | Industry News
      Stevanato Group Launches After-sales Service Offering

      Stevanato Group Launches After-sales Service Offering

      Aims to deliver a more customized experience for optimal machine maintenance, performance and utilization.
      Kristin Brooks 01.26.21

    • Breaking News | Drug Discovery | Industry News | Preclinical Outsourcing
      X-Chem Acquires IntelliSyn and AviSyn

      X-Chem Acquires IntelliSyn and AviSyn

      Acquisitions allow the company to offer services for screening, hit validation and lead optimization on existing and new markets.
      Kristin Brooks 01.26.21

    • Breaking News | Capsules | Cold Chain Management | Fill/Finish | Industry News | Solid Dosage/Semi-solids
      Aphena’s $21M Cookeville Expansion Nears Completion

      Aphena’s $21M Cookeville Expansion Nears Completion

      Bottle packaging capacity has been expanded with the installation of 10 high-speed bottling lines to start.
      Kristin Brooks 01.26.21


    • Breaking News | Collaborations & Alliances
      BioMed X, Janssen Enter Oral Drug Delivery Alliance

      BioMed X, Janssen Enter Oral Drug Delivery Alliance

      Aims to discover novel transport mechanisms which could be utilized for oral delivery of therapeutic modalities.
      Charles Sternberg, Assistant Editor 01.26.21

    • Breaking News | Clinical Trials | Industry News
      Care Access Research, AstraZeneca Partner on COVID-19 Antibody Trial

      Care Access Research, AstraZeneca Partner on COVID-19 Antibody Trial

      Care Access to provide decentralized, mobile research site operations for AstraZeneca’s AZD7442 Phase III trial in the U.S.
      Kristin Brooks 01.26.21

    • Breaking News
      500+ Sites Join Inato’s Industry Marketplace

      500+ Sites Join Inato’s Industry Marketplace

      Platform aims to make clinical research more inclusive and efficient.
      Charles Sternberg, Assistant Editor 01.26.21


    • Breaking News | Clinical Trials | Drug Development | Industry News | Laboratory Testing
      Caprion-HistoGeneX Rebrands as CellCarta

      Caprion-HistoGeneX Rebrands as CellCarta

      Recently expanded its scientific capabilities and geographic presence with the acquisitions of Clinical Logistics Inc. and Mosaic Laboratories.
      Kristin Brooks 01.26.21

    • Breaking News | cGMP Manufacture | Excipients | Industry News
      PromoCell Receives EXCiPACT Certification

      PromoCell Receives EXCiPACT Certification

      Manufactures pharmaceutical excipients to GMP standards for tailor-made cell culture media and reagents that fulfill specific regulatory requirements.
      Kristin Brooks 01.26.21

    • Breaking News | Facilities | Industry News | Injectables | Parenterals
      Civica to Build an Essential Medicines Manufacturing Facility in Virginia

      Civica to Build an Essential Medicines Manufacturing Facility in Virginia

      Will produce sterile injectable meds used in hospitals for COVID-19 patient care.
      Tim Wright, Editor, Contract Pharma 01.25.21


    • Bio News | Breaking News | Clinical Trial Materials | Clinical Trials | Collaborations & Alliances | Industry News
      Humanigen, Emergent Enter Covid-19 Partnership

      Humanigen, Emergent Enter Covid-19 Partnership

      Sign contract development and manufacturing agreement for Phase 3 COVID-19 therapeutic candidate lenzilumab.
      Tim Wright, Editor, Contract Pharma 01.25.21

    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Facilities | Industry News
      Samsung Bioepis Opens New Headquarters

      Samsung Bioepis Opens New Headquarters

      The 52,000-square-foot campus to become the hub of Samsung Bioepis’ drive for accelerated development of next-gen biologic medicines.
      Tim Wright, Editor, Contract Pharma 01.25.21

    • Breaking News | Industry News
      Pfizer, BioNTech Enter Vax Pact with COVAX

      Pfizer, BioNTech Enter Vax Pact with COVAX

      Initial agreement provides up to 40 million doses of the Pfizer-BioNTech COVID-19 Vaccine to COVAX in 2021, with first deliveries expected in 1Q21.
      Kristin Brooks 01.22.21


    • Breaking News | Trials & Filings
      FDA Approves Janssen’s CABENUVA

      FDA Approves Janssen’s CABENUVA

      Becomes first and only once-monthly, long-acting regimen for the treatment of HIV infection.
      Kristin Brooks 01.22.21

    • Breaking News | Promotions & Moves
      AGC Biologics Appoints Boulder Site GM

      AGC Biologics Appoints Boulder Site GM

      David Stewart to oversee the startup, strategic development and operational excellence in large-scale biologics production at the Boulder, CO site.
      Kristin Brooks 01.22.21

    • Breaking News | Drug Development | Drug Discovery | Industry News
      Lilly Completes $1B Acquisition of Prevail

      Lilly Completes $1B Acquisition of Prevail

      Adds new modality for drug discovery and development and creates a gene therapy program with neuroscience assets.
      Kristin Brooks 01.22.21

    Trending
    • Integrated Continuous Manufacturing ICM
    • Humanigen, Emergent Enter Covid-19 Partnership
    • Samsung Bioepis Opens New Headquarters
    • CDMO Northway Biotech Expands In U.S.
    • CONTINUUS Awarded $69.3M DoD Grant
    Breaking News
    • Stevanato Group Launches After-sales Service Offering
    • X-Chem Acquires IntelliSyn and AviSyn
    • Aphena’s $21M Cookeville Expansion Nears Completion
    • BioMed X, Janssen Enter Oral Drug Delivery Alliance
    • Care Access Research, AstraZeneca Partner on COVID-19 Antibody Trial
    View Breaking News >
    CURRENT ISSUE

    November/December 2020

    • Modeling Process Safety Workflows in Pharmaceutical Manufacturing Scale-Up
    • Ensuring Quality During the Transfer and Scale Up of Rx Drugs
    • Inspecting the Unexpected
    • Cold Chain Trends
    • Catering for the Complex
    • Biopharma Contract Manufacturing: Robust Growth Ahead
    • DCAT President Talks COVID-19, Drug Manufacturing and Innovation
    • The Single-Use Mixing Landscape: Evaluating Your Options
    • Self-Medication: Flexibility for Patients and Drug Manufacturers
    • Decentralized Trials Fuel AI Revolution in Clinical Research
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Kerry Launches Web-Based Tool for Plant-Based Formulation Challenges
    Wiley’s Finest Earns Accolades for Taste of Omega-3 Products
    Clinical Evidence Suggests Potential Oral Benefits for Curcumin Extract
    Coatings World

    Latest Breaking News From Coatings World

    Scott McLaughlin to Race in PPG Colors During Rookie INDYCAR Season
    Vink Chemicals Offers parmetol PSG
    Palmer Holland Expands Roles, Positions Of Business Teams
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Butterfly Network Appoints New Leader
    BD Names Chairman of Board
    Interplex Acquires OCP Group
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Stevanato Group Launches After-sales Service Offering
    X-Chem Acquires IntelliSyn and AviSyn
    Aphena’s $21M Cookeville Expansion Nears Completion
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    The Estée Lauder Companies Announces Game-Changing Sustainability Goals for Travel Retail
    Aura Introduces Customizable Hair Care
    Corpack Creates Custom Packaging for Marlies Möller Hair Care Line
    Happi

    Latest Breaking News From Happi

    Harry’s Launches ‘Headquarters’
    Henkel Recognizes Top Suppliers
    Estée Lauder Travel Retail's Sustainability Goals
    Ink World

    Latest Breaking News From Ink World

    Smurfit Kappa Sets New Sustainability Targets with Better Planet 2050
    Paragon Expands Direct Mail Capabilities with Ricoh Pro VC70000
    Rondo Ganahl Adds Koenig & Bauer Durst Delta SPC 130
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Great Lakes Label debuts new website
    Epson partner creates label applicators for pharmaceutical products
    ACTEGA removes chemicals from laminating adhesives
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    American Made Production Equipment for Mask Manufacturers
    Kimberly-Clark Releases Q4, Full Year Results
    Freudenberg to Establish Apparel Interlining Competence Centers
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Spinal Elements' Lucent XP-Curved Expandable TLIF Gains FDA Nod
    FDA OKs OrthoSpin's 2nd Gen Robotic, Digital External Fixation System
    Nextremity Solutions Enters Supply Agreement with Fort Wayne Metals
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    North American Semiconductor Equipment Industry Posts December 2020 Billings
    First Solar Signs Definitive Agreement to Sell US Development Platform to Leeward
    PRINTING United Alliance Announces TAGA Presents Virtual Event

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login